 Ampio Pharmaceuticals, Inc. NYSE American: AMPE the Company, is a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions. As part of this program, the Company is developing therapies for patients infected with the SARS-CoV-2 virus COVID-19. 